An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs

Vaccine

Volumn 19, Issue 4-5, 2000, Pages 475-482

  Dewulf, J ^a,b   Laevens, H ^a,b   Koenen, F ^c   Vanderhallen, H ^c   Mintiens, K ^a,b   Deluyker, H ^d   De Kruif, A ^a  

^a Obstet Herd Hlth Sch Vet M   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^d Pharmacia and Upjohn Co ordination Centre   (Belgium)

Author keywords

Classical swine fever; Pigs; Vaccination

Indexed keywords

PROCILIS; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; SWINE DISEASE; VACCINATION; VACCINE PRODUCTION; VIRUS TRANSMISSION;

ANIMAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; SUPPORT, NON-U.S. GOV'T; SWINE; TIME FACTORS; VACCINATION; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0034668217     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00189-4     Document Type: Article

References (22)

1. Pensaert M., van Reeth K. Vaccines for swine, classical swine fever. Pastoret P., Blancou J., Vannier P., Verschueren C. Veterinary Vaccinology. 1997;374-375 Elsevier, Amsterdam.
2. Miry C., Castryck F., Koenen F., Broers A., Segers E. Quelques aspects de l'epizootie de peste porcine classique en Belgique en 1990. Epidémiol Santé Animal. 20:1991;23-32.
3. Pittler H., Fiedler J., Jentsch D., Hasselbach P., Kramer M. Problems arising from the course of swine fever in Germany during 1993/1994, and their consequences. Tierarztliche Umschau. 50:1995;522-526.
4. Mintiens K., Deluyker H., Laevens H., Koenen F., Dewulf J., de Kruif A. Classical swine fever outbreak in the Limburg province of Belgium (1997). Laevens H., Vandenheede J. Proceedings of the 7th Annual Meeting of the Belgian Society for Veterinary Epidemiology and Economics. Antwerp. 1999;136-143.
5. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol. 69:(10):1995;6479-6486.
6. van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J. Gen. Virol. 77:(11):1996;2737-2745.
7. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra C., Moormann R.J. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet. Microbiol. 66:(2):1999;101-114.
8. Bouma A., de Smit A.J., de Jong M.C., de Kluijver E.P., Moormann R.J. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine. 18:(14):2000;1374-1381.
9. Anonymous. The use of marker vaccines in the control of infectious diseases in particular, classical swine fever. Report of the Scientific Veterinary Committee. Scientific Veterinary Committee of the European Commission. 1997.
10. Koenen F., Lefebvre J. Kinetics of an experimental infection with a classical swine fever (CSF) field isolate. Proceedings of the 3rd Congress Europ. Soc. of Vet. Virol. 1995;322-326.
11. Intervet. Porcilis Pesti. Overview of information currently available. 1997. pp. 56-71.
12. McGoldrick A., Bensaude E., Ibata G., Sharp G., Paton D.J. Closed one-tube reverse transcription nested polymerase chain reaction for the detection of pestiviral RNA with fluorescent probes. J. Virol. Methods. 79:(1):1999;85-95.
13. Laevens H., Koenen F., Deluyker H., Berkvens D., de Kruif A. An experimental infection with classical swine fever virus in weaner pigs. I. Transmission of the virus, course of the disease, and antibody response. Vet. Q. 20:(2):1998;41-45.
14. Laevens H., Koenen F., Deluyker H., de Kruif A. Experimental infection of slaughter pigs with classical swine fever virus: transmission of the virus, course of the disease and antibody response. Veterinary Record. 145:(9):1999;243-248.
15. Roberts M. Evaluation of optimal size of restriction zones in disease control with particular references to classical swine fever. Goodall E.A. Proceedings of a Meeting of the Society for Veterinary Epidemiology and Preventive Medicine; Reading, UK. 1995;119-130.
16. Laevens H. Risk factors for the transmission of classical swine fever virus to herds in the close neighbourhood of an infected herd. Epizootiology of classical swine fever: experimental infections simulating field conditions, and risk factors for virus transmission in the neighbourhood of an infected herd. 1999;103-121 Ghent University, Ghent.
17. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:(9):1993;5435-5442.
18. Peeters B., Bienkowska S.K., Hulst M., Gielkens A., Kimman T. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J. Gen. Virol. 78:(12):1997;3311-3315.
19. Rumenapf T., Stark R., Meyers G., Thiel H.J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J. Virol. 65:(2):1991;589-597.
20. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der G.H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65:(5):1991;2761-2765.
21. Terpstra C., Wensvoort G. Influence of the vaccination regime on the herd immune response for swine fever. Vet. Microbiol. 13:(2):1987;143-151.
22. Terpstra C., Robijns K.G. Experience with regional vaccination against swine fever in enzootic areas for limited periods using C-strain virus. Tijdschr Diergeneeskd. 102:(2):1977;106-112.